Trademark: 79226295
Word

Status
Registered
Status Code
700
Status Date
Tuesday, July 31, 2018
Serial Number
79226295
Registration Number
5527128
Registration Date
Tuesday, July 31, 2018
Mark Type
2000
Filing Date
Tuesday, November 14, 2017
Published for Opposition
Tuesday, May 15, 2018

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
The mark consists of two blue and purple angular, flowing shapes.
The color(s) blue and purple is/are claimed as a feature of the mark.

Trademark Events
Jul 31, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Dec 8, 2018
Final Decision Transaction Processed By Ib
Nov 16, 2018
Final Disposition Notice Sent To Ib
Nov 16, 2018
Final Disposition Processed
Oct 31, 2018
Final Disposition Notice Created, To Be Sent To Ib
Jul 31, 2018
Registered-Principal Register
May 15, 2018
Official Gazette Publication Confirmation E-Mailed
May 15, 2018
Published For Opposition
Apr 25, 2018
Notification Of Notice Of Publication E-Mailed
Apr 12, 2018
Assigned To Lie
Apr 5, 2018
Approved For Pub - Principal Register
Mar 30, 2018
Refusal Processed By Ib
Mar 22, 2018
Teas/Email Correspondence Entered
Mar 22, 2018
Correspondence Received In Law Office
Mar 22, 2018
Teas Response To Office Action Received
Mar 16, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 16, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 12, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Mar 12, 2018
Refusal Processed By Mpu
Mar 6, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Mar 5, 2018
Non-Final Action Written
Feb 26, 2018
Assigned To Examiner
Feb 16, 2018
Application Filing Receipt Mailed
Feb 12, 2018
New Application Office Supplied Data Entered
Feb 9, 2018
Limitation From Original Application Entered
Feb 8, 2018
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24